早期的研究已经显示,对慢性乙型肝炎e抗原阴性的患者进行48周阿德福韦治疗后,获得了临床上的改善。
Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.
早期的研究已经显示,对慢性乙型肝炎e抗原阴性的患者进行48周阿德福韦治疗后,获得了临床上的改善。
Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.
应用推荐